Dr. Reddy’s Elyxyb (celecoxib oral solution) Receives the US FDA’s Approval for Acute Treatment of Migraine with or Without Aura in Adults
Dr. Reddy’s Laboratories Launches Versavo (biosimilar, bevacizumab) for Multiple Cancers in India
Shots:
- ELYXYB (previously as DFN-15) is an oral solution formulated using a self-micro emulsifying drug delivery system helps in improving solubility and bioavailability of the drug leading for absorption
- The candidate demonstrated a rapid onset of actions important for suffering from acute migraine and resulted in efficacy with few AEs
- NSAIDs including ELYXYB can lead to increase the risk of bleeding events also co-morbid conditions such as coagulation disorders
Click here to read full press release/ article | Ref: Business Wire | Image: Twitter